Conference abstractPublished 2 Oct 2017
Automated drug design of kinase inhibitors to treat chronic myeloid leukemia
King Abdulaziz University, Saudi Arabia University of Surrey, UK
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Medicinal chemistry has in the past been dominated by learned insights from experienced organic chemists. However, with the advent of computer based methods, computer aided drug design has become prominent. We have compared here the ability of expert chemists to purely automated methods and found that the automated method produces a better potential candidate drug than the expert input. The example chosen is based on inhibitors to Abl-kinase and the successful anti-leukaemic drug imatinib. The proposed molecule is a simple modification of nilotinib which has a docking energy of 4.2 kJ/mol better than the best intuitive molecule.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Aramice Y S Malkhasian”
- BylineArticles whose byline prints “Brendan J Howlin”
